EADOX | EIDOX | EADOX / EIDOX | |
Total Expense Ratio | 1.15 | 0.91 | 126% |
Annual Report Gross Expense Ratio | 1.15 | 0.91 | 126% |
Fund Existence | 10 years | 10 years | - |
Gain YTD | 11.590 | 11.921 | 97% |
Front Load | 3% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.9B | 3.9B | 100% |
Annual Yield % from dividends | 7.89 | 8.14 | 97% |
Returns for 1 year | 14.36 | 14.77 | 97% |
Returns for 3 years | 53.07 | 54.35 | 98% |
Returns for 5 years | 39.58 | 41.32 | 96% |
Returns for 10 years | 94.88 | 100.64 | 94% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFAX | 14.53 | 0.10 | +0.69% |
AlphaCentric Life Sciences & Hlthcare A | |||
PLCGX | 18.43 | 0.10 | +0.55% |
Principal LargeCap Growth I R6 | |||
NQVAX | 60.44 | 0.31 | +0.52% |
Nuveen Multi Cap Value A | |||
IBNYX | 25.94 | 0.07 | +0.27% |
Macquarie Balanced Fund Class Y | |||
EMFIX | 13.67 | -0.06 | -0.44% |
Ashmore Emerging Markets Equity Instl |